Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Jorma J. Mattila"'
Autor:
VäinäMÖ T. A. Nikkanen, Jorma J. Mattila, Vesa V. Kataja, Pasi A. Koivisto, Antti T. Ojala, Markku M. T. Virén
Publikováno v:
Medical Oncology. 14:35-38
Flow cytometric (FCM) analysis of tumor DNA ploidy and S-phase fraction (SPF) has been widely used to predict prognosis and treatment response in many malignant tumors, but rarely in small-cell lung cancer (SCLC). In the present study, tumor DNA ploi
Autor:
Juha-Pekka Salenius, Antti Ojala, Jorma J. Mattila, Tuija Wigren, Jari Tapio Ikonen, Heikki Riekkinen
Publikováno v:
Scandinavian cardiovascular journal : SCJ. 33(4)
Although DNA aneuploidy and high proliferative activity (S-phase fraction, SPF) of tumour cells, measured by flow cytometry, have proved to be indicators of poor prognosis in most solid tumours, there have been conflicting results in lung cancer stud
Autor:
Rantanen T; Department of Gastroenterology and Alimentary Tract Surgery, Tampere University Hospital, Tampere., Oksala N, Honkanen T, Räsänen J, Sihvo E, Mattila J, Paimela H, Paavonen T, Salo J
Publikováno v:
Journal of digestive diseases [J Dig Dis] 2011 Aug; Vol. 12 (4), pp. 263-71.
Autor:
Halonen P; Paediatric Research Centre, Medical School, University of Tampere, Tampere, Finland. paivi.halonen@hus.fi, Mattila J, Mäkipernaa A, Ruuska T, Schmiegelow K
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2006 Jun; Vol. 46 (7), pp. 762-6.
Autor:
Halonen P; Paediatric Research Centre, Medical School, University of Tampere, Tampere, Finland. paivi.halonen@kotiposti.net, Mattila J, Ruuska T, Salo MK, Mäkipernaa A
Publikováno v:
Medical and pediatric oncology [Med Pediatr Oncol] 2003 Mar; Vol. 40 (3), pp. 148-54.
Autor:
Halonen P; Paediatric Research Centre, Medical School, University of Tampere, Tampere, Finland. paivi.halonen@kotiposti.net, Mattila J, Suominen P, Ruuska T, Salo MK, Mäkipernaa A
Publikováno v:
Pediatrics [Pediatrics] 2003 Jan; Vol. 111 (1), pp. 91-6.